Male Contraceptive Initiative supports science that moves male contraceptives forward. ​We support a broad program of research including discovery-stage and pre-clinical studies across the drug and device realms. We also support young researchers, development of tools that promote the field, and social science that illustrates the demand and need for male contraceptives.
MCI-BCM Sponsored Target Screening
​This opportunity will facilitate the screening of validated male contraceptive targets for small-molecule inhibitors using the DNA-Encoded Chemistry Technology (DEC-Tec) core facilities available in the lab of Dr. Martin Matzuk and Center for Drug Discovery at Baylor College of Medicine (BCM). The purpose of this opportunity is to allow investigators with validated male contraceptive targets to utilize state-of-the-art screening facilities to identify “hit” molecules that bind to the target of interest. Deadline: Rolling
Trainee Fellowships
​​Male Contraceptive Initiative is committed to nurturing the next generation of researchers in male contraception. Our fellowship program provides support to graduate students and postdoctoral trainees working with leading investigators in the field. Deadline: TBA
Trainee Success Program
Male Contraceptive Initiative is dedicated to supporting the career development of graduate and postdoctoral trainees passionate about male contraception research. Our Success program provides ongoing funding for activities and resources that directly advance your career in this field. Deadline: Rolling
The Beverly Tucker Award
Named after our esteemed founding board member, Beverly Tucker, MPH, MPIA, PMP, the Tucker Award recognizes the importance of international collaboration and professional development in the field of global health. Deadline: Rolling
​
Sponsor Institute/Organizations: Male Contraceptive Initiative
Sponsor Type:
Address: NA
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Rolling Deadlines. Please check the grant website for full details
Varies
Affiliation: Male Contraceptive Initiative
Address: NA
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.